Two experts address the impact of disease course on therapy, general instructions for patients, individualizing treatment, thymectomy, newer selective immunotherapies and more.
Read MoreMyasthenia Gravis: Frequently Asked Questions About Evaluation and Diagnosis
Two experts address the clinical hallmarks of this chronic autoimmune neuromuscular disorder as well as risk factors and the role of antibody testing and electrodiagnostic tests.
What Are the Treatment Options for Myasthenia Gravis if First-Line Agents Fail?
For the 5% to 20% of patients with generalized myasthenia gravis who have suboptimal response to pyridostigmine or substantial adverse effects, it may be time to consider immunosuppressive therapy. This short review offers guidance on choice of agents.
Survey Suggests Opportunities to Curb ALS Diagnostic Delay Through Primary Care Education
Early diagnosis of amyotrophic lateral sclerosis yields substantial benefits for patients and therapeutic trial enrollment. A new study identifies ways to empower PCPs to help speed diagnosis.
Mild COVID-19 Linked to Postural Orthostatic Tachycardia Syndrome
Postural orthostatic tachycardia syndrome (POTS) appears to be a component of long COVID in some people following even mild SARS-CoV-2 infection, a large case series suggests.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Peripheral Nerve Neurosurgery: How a Nascent Subspecialty Can Improve Outcomes After Nerve Injuries
Referral for peripheral nerve neurosurgery is best done within three months of a nerve injury. Our new peripheral nerve neurosurgeon shares this and other insights about her little-understood subspecialty.